Healthcare provider profile · identity verified

Shawn E Bailey, MD

Allopathic & Osteopathic Physicians|Family Medicine · GRANVILLE, IL · NPI 1447363585

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Shawn E Bailey, MD received $199.61 in general payments during 2025 across 4 reported records.

Abbott Laboratories accounted for 51.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Zenpep.

Aimmune Therapeutics, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ZENPEP as an associated drug or biological on 32144 records involving 12432 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Zenpep by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$199.61

4 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Abbott Laboratories	Unresolved — no canonical attribution shown	$102.10	51.1%	1	2025
Aimmune Therapeutics, Inc.	Unresolved — no canonical attribution shown	$62.35	31.2%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$35.16	17.6%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$199.61	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
FREESTYLE LIBRE 3 Normalized: freestyle libre 3	Device	Abbott Laboratories	$102.10	1	2025
Source payment records 2025-04-30 · Abbott Laboratories · $102.10 · Open Payments source
ZENPEP Normalized: zenpep	Drug	Aimmune Therapeutics, Inc.	$62.35	1	2025
Source payment records 2025-10-08 · Aimmune Therapeutics, Inc. · $62.35 · Open Payments source
The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit	Device	Exact Sciences Corporation	$35.16	2	2025
Source payment records 2025-06-18 · Exact Sciences Corporation · $21.20 · Open Payments source 2025-08-13 · Exact Sciences Corporation · $13.96 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
ZENPEP zenpep	2025	Zenpep	2024	11 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Aimmune Therapeutics, Inc. Exact reporting entity; no affiliate inference	2025	ZENPEP open payments reported associated product	CMS Open Payments — General Payments 32144 supporting records · 12432 recipient NPIs · example record 1249641927	Zenpep · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	835	212
Levothyroxine Sodium	Levothyroxine Sodium	570	127
Lisinopril	Lisinopril	502	117
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	403	71
Amlodipine Besylate	Amlodipine Besylate	390	93
Metoprolol Succinate	Metoprolol Succinate	328	81
Simvastatin	Simvastatin	310	74
Metformin Hcl	Metformin Hcl	307	75
Omeprazole	Omeprazole	300	70
Pantoprazole Sodium	Pantoprazole Sodium	280	64
Lorazepam	Lorazepam	273	45
Allopurinol	Allopurinol	256	68
Citalopram Hbr	Citalopram Hydrobromide	233	49
Prednisone	Prednisone	229	72
Gabapentin	Gabapentin	228	51
Alprazolam	Alprazolam	223	38
Metoprolol Tartrate	Metoprolol Tartrate	221	57
Eliquis	Apixaban	208	31
Tramadol Hcl	Tramadol Hcl	194	35
Duloxetine Hcl	Duloxetine Hcl	191	42
Albuterol Sulfate Hfa	Albuterol Sulfate	172	53
Losartan Potassium	Losartan Potassium	165	45
Hydrochlorothiazide	Hydrochlorothiazide	162	38
Potassium Chloride	Potassium Chloride	160	37
Furosemide	Furosemide	153	43
Farxiga	Dapagliflozin Propanediol	151	26
Meloxicam	Meloxicam	150	38
Zolpidem Tartrate	Zolpidem Tartrate	146	25
Atenolol	Atenolol	138	32
Tamsulosin Hcl	Tamsulosin Hcl	125	34
Methylprednisolone	Methylprednisolone	123	97
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	119	23
Rosuvastatin Calcium	Rosuvastatin Calcium	104	26
Jardiance	Empagliflozin	95	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	80	11
Ozempic	Semaglutide	78	12
Azithromycin	Azithromycin	76	58
Clopidogrel	Clopidogrel Bisulfate	76	19
Ropinirole Hcl	Ropinirole Hcl	75	13
Fluticasone Propionate	Fluticasone Propionate	74	21
Montelukast Sodium	Montelukast Sodium	73	22
Metformin Hcl Er	Metformin Hcl	72	15
Carvedilol	Carvedilol	71	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	68	suppressed
Pravastatin Sodium	Pravastatin Sodium	68	18
Famotidine	Famotidine	66	13
Celecoxib	Celecoxib	65	16
Sertraline Hcl	Sertraline Hcl	65	18
Triamcinolone Acetonide	Triamcinolone Acetonide	63	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	14
Entresto	Sacubitril/Valsartan	58	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	58	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	13
Fluoxetine Hcl	Fluoxetine Hcl	54	suppressed
Testosterone Cypionate	Testosterone Cypionate	54	suppressed
Fluconazole	Fluconazole	51	16
Trazodone Hcl	Trazodone Hcl	51	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	51	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	50	12
Clonazepam	Clonazepam	49	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	48	suppressed
Topiramate	Topiramate	47	suppressed
Glimepiride	Glimepiride	46	suppressed
Spironolactone	Spironolactone	46	13
Synthroid	Levothyroxine Sodium	46	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Benazepril Hcl	Benazepril Hcl	43	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	43	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	42	suppressed
Lamotrigine	Lamotrigine	42	suppressed
Pregabalin	Pregabalin	42	suppressed
Warfarin Sodium	Warfarin Sodium	41	suppressed
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Ibuprofen	Ibuprofen	39	suppressed
Donepezil Hcl	Donepezil Hcl	37	suppressed
Ventolin Hfa	Albuterol Sulfate	37	suppressed
Aripiprazole	Aripiprazole	36	suppressed
Enalapril Maleate	Enalapril Maleate	36	suppressed
Propranolol Hcl	Propranolol Hcl	36	suppressed
Invokana	Canagliflozin	35	suppressed
Repatha Sureclick	Evolocumab	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	33	suppressed
Meclizine Hcl	Meclizine Hcl	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	12
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Diazepam	Diazepam	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Tresiba Flextouch U-100	Insulin Degludec	28	suppressed
Baclofen	Baclofen	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	22
Clonidine Hcl	Clonidine Hcl	26	suppressed
Irbesartan	Irbesartan	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Estradiol	Estradiol	25	suppressed
Klor-Con M20	Potassium Chloride	25	12
Memantine Hcl	Memantine Hcl	25	suppressed
Methotrexate	Methotrexate Sodium	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Carbamazepine Er	Carbamazepine	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	19
Amoxicillin	Amoxicillin	22	16
Mounjaro	Tirzepatide	22	suppressed
Naproxen	Naproxen	22	suppressed
Colchicine	Colchicine	21	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	20	suppressed
Levemir Flexpen	Insulin Detemir	20	suppressed
Roflumilast	Roflumilast	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Liothyronine Sodium	Liothyronine Sodium	19	suppressed
Lurasidone Hcl	Lurasidone Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	13
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Primidone	Primidone	17	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	17	suppressed
Sulfasalazine	Sulfasalazine	17	suppressed
Tiadylt Er	Diltiazem Hcl	17	suppressed
Finasteride	Finasteride	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Indapamide	Indapamide	15	suppressed
Linzess	Linaclotide	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Phenobarbital	Phenobarbital	15	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	15	suppressed
Cephalexin	Cephalexin	14	14
Labetalol Hcl	Labetalol Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Opium Tincture	Opium Tincture	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Trandolapril	Trandolapril	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Dapsone	Dapsone	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Temazepam	Temazepam	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Bicalutamide	Bicalutamide	11	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Zenpep	Lipase/Protease/Amylase	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$199.61 · 4 records	Abbott Laboratories	FREESTYLE LIBRE 3, The Cologuard Plus Collection Kit, ZENPEP	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Zenpep play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Aimmune Therapeutics, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error